Updated Questions and Answers
(2026/2027) | Review Guide | Grade A+
DOMAIN 1: PHARMACOKINETICS & PHARMACODYNAMICS
Question 1
A patient with hepatic impairment is prescribed a medication metabolized by the
CYP3A4 enzyme system. Which pharmacokinetic process will be most
significantly affected?
• A) Absorption
• B) Distribution
• C) Metabolism
• D) Excretion
✅ Correct Answer: C
Rationale: The liver is the primary site of drug metabolism, particularly Phase I
reactions mediated by the Cytochrome P450 (CYP) enzyme system. Hepatic
impairment reduces the liver's capacity to metabolize drugs, leading to increased
drug concentration and a prolonged half-life.
,Question 2
A drug that binds to a receptor and produces a maximal biological response is
classified as:
• A) Partial agonist
• B) Antagonist
• C) Agonist
• D) Inverse agonist
✅ Correct Answer: C
Rationale: An agonist binds to a receptor and activates it, producing a full
response. An antagonist binds but does not activate the receptor, blocking the
action of agonists.
Question 3
A patient in renal failure is prescribed gentamicin. The nurse anticipates that the
dosing interval will need to be extended due to a decrease in which parameter?
• A) Bioavailability
• B) Volume of distribution
• C) Clearance
• D) First-pass effect
✅ Correct Answer: C
Rationale: Clearance is the volume of plasma from which a drug is completely
removed per unit time. Gentamicin is primarily eliminated unchanged by the
kidneys via glomerular filtration. In renal failure, clearance is significantly
reduced, leading to drug accumulation and increased risk of nephrotoxicity and
ototoxicity.
,Question 4
What is the therapeutic index (TI), and why is it clinically important?
• A) The ratio between a drug's toxic dose and its therapeutic dose; a low TI
indicates a narrow margin of safety
• B) The time it takes for a drug to reach steady state
• C) The percentage of drug that reaches systemic circulation
• D) The measure of drug distribution into body tissues
✅ Correct Answer: A
Rationale: The TI is the ratio between a drug's toxic dose and its therapeutic dose
(TD50/ED50). A low TI indicates a narrow margin of safety, requiring close
monitoring (e.g., Warfarin, Digoxin).
Question 5
An elderly patient has increased adipose tissue and decreased lean body mass. How
would this affect the distribution of diazepam, a lipophilic drug?
• A) Decreased volume of distribution and shorter half-life
• B) Increased volume of distribution and prolonged half-life
• C) No significant change in distribution
• D) Increased plasma protein binding
✅ Correct Answer: B
Rationale: Lipophilic drugs distribute into adipose (fat) tissue. With aging,
increased body fat serves as a reservoir for these drugs, leading to a larger volume
, of distribution and a prolonged half-life as the drug is slowly released from fat
stores over time.
Question 6
The half-life of warfarin is significantly increased when co-administered with
fluconazole. This is most likely due to:
• A) Increased gastrointestinal absorption
• B) Decreased plasma protein binding
• C) Inhibition of CYP2C9 metabolism
• D) Increased renal excretion
✅ Correct Answer: C
Rationale: Warfarin is a narrow-therapeutic-index drug metabolized by the
CYP2C9 enzyme. Fluconazole is a potent inhibitor of CYP2C9. This inhibition
reduces warfarin metabolism, increasing its levels and the risk of bleeding.
Question 7
What is the significance of a drug's half-life?
• A) It determines the time to reach steady state and the dosing frequency
• B) It measures the drug's affinity for its receptor
• C) It indicates the drug's volume of distribution
• D) It predicts the drug's bioavailability
✅ Correct Answer: A